| Literature DB >> 22226351 |
Weiping Yuan1, Douglas Sipp, Zack Z Wang, Hongkui Deng, Duanqing Pei, Qi Zhou, Tao Cheng.
Abstract
China's output in fundamental stem cell research has increased markedly in recent years. Vigorous public investment and infrastructure development have enabled major productivity gains, but challenges in regulation, governance, and the management of clinical expectations must be addressed to ensure scientific quality and sustainable growth.Mesh：
Year: 2012 PMID： 22226351 DOI： 10.1016/j.stem.2011.12.002
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633